Author:
Jansen-West Karen,Todd Tiffany W.,Daughrity Lillian M.,Yue Mei,Tong Jimei,Carlomagno Yari,Del Rosso Giulia,Kurti Aishe,Jones Caroline Y.,Dunmore Judith A.,Castanedes-Casey Monica,Dickson Dennis W.,Wszolek Zbigniew K.,Fryer John D.,Petrucelli Leonard,Prudencio Mercedes
Abstract
Spinocerebellar ataxia type 3 (SCA3) is a dominantly inherited cerebellar ataxia caused by the expansion of a polyglutamine (polyQ) repeat in the gene encoding ATXN3. The polyQ expansion induces protein inclusion formation in the neurons of patients and results in neuronal degeneration in the cerebellum and other brain regions. We used adeno-associated virus (AAV) technology to develop a new mouse model of SCA3 that recapitulates several features of the human disease, including locomotor defects, cerebellar-specific neuronal loss, polyQ-expanded ATXN3 inclusions, and TDP-43 pathology. We also found that neurofilament light is elevated in the cerebrospinal fluid (CSF) of the SCA3 animals, and the expanded polyQ-ATXN3 protein can be detected in the plasma. Interestingly, the levels of polyQ-ATXN3 in plasma correlated with measures of cerebellar degeneration and locomotor deficits in 6-month-old SCA3 mice, supporting the hypothesis that this factor could act as a biomarker for SCA3.
Funder
National Institute of Neurological Disorders and Stroke
Sol Goldman Charitable Trust
Mayo Clinic
Albertson Parkinson’s Research Foundation
National Institute on Aging
Subject
Cell Biology,Developmental Biology
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献